Low- and middle-income countries
44 articles
Widespread Hepatitis C Virus Transmission Network Among People Who Inject Drugs in Kenya
A study performed a novel genetic analysis of hepatitis C virus transmission networks among people who inject drugs in Kenya. More
First Self-Test for Hepatitis C Virus
Whereas affordable HCV self-testing can improve HCV screening, the price and availability of virologic testing, required to confirm HCV diagnosis prior to treatment, remains a major obstacle to HCV elimination in LMICs and must be urgently addressed. More
Understanding Barriers to Hepatitis C Antiviral Treatment in Low–Middle-Income Countries
Through a structured search of open access informational sources and an informal peer-reviewed literature review, HCV treatment barriers were identified, compiled, analysed and summarized as recommendations for LMICs. More
Health Economic Outcomes of a Minimal Monitoring Approach to Providing HCV Therapy
The ACTG A5360 trial demonstrated that HCV treatment without planned on-treatment monitoring is safe and effective. More
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
TAG releases an advocacy brief discussing findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on potential long-acting therapies for HCV cure. More
